Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 492-498

  Ross, Allison C ^a   O'Riordan, Mary Ann ^a   Storer, Norma ^a   Dogra, Vikram ^b   McComsey, Grace A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Cardiovascular disease; Children; HIV; Hyperlipidemia; Inflammation

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LIPID; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CELL ACTIVATION; CHILD; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GROUPS BY AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNAL CAROTID ARTERY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFLAMMATION; MALE; PROSPECTIVE STUDIES; TUNICA INTIMA; TUNICA MEDIA;

EID: 77955267131     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.04.008     Document Type: Article

References (35)

1. Obel N., Thomsen H.F., Kronborg G., et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007, 44(12):1625-1631.
2. Triant V.A., Lee H., Hadigan C., Grinspoon S.K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007, 92(7):2506-2512.
3. Charakida M., Donald A.E., Green H., et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 2005, 112(July (1)):103-109.
4. Giuliano Ide C., de Freitas S.F., de Souza M., Caramelli B. Subclinic atherosclerosis and cardiovascular risk factors in HIV-infected children: PERI study. Coron Artery Dis 2008, 19(3):167-172.
5. McComsey G.A., O'Riordan M., Hazen S.L., et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007, 21(May (8)):921-927.
6. Bonnet D., Aggoun Y., Szezepanski I., Bellal N., Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 2004, 18(April (7)):1037-1041.
7. Ross A.C., Armentrout R., O'Riordan M.A., et al. Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J Acquir Immune Defic Syndr 2008, 49:499-506.
8. Torriani F.J., Komarow L., Parker R.A., et al. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol 2008, 52(August (7)):569-576.
9. Kuller L.H., Tracy R., Belloso W., et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5(October (10)):e203.
10. Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003, 349(October (17)):1595-1604.
11. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101(May (18)):2149-2153.
12. Amar J., Fauvel J., Drouet L., et al. Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecule 1. J Hypertens 2006, 24(June (6)):1083-1088.
13. Chung N.A., Lydakis C., Belgore F., Li-Saw-Hee F.L., Blann A.D., Lip G.Y. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart 2003, 89(December (12)):1411-1415.
14. Pai J.K., Pischon T., Ma J., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004, 351(December (25)):2599-2610.
15. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347(November (20)):1557-1565.
16. Irwin M.W., Mak S., Mann D.L., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 1999, 99(11):1492-1498.
17. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001, 286(November (17)):2136-2142.
18. Hwang S.J., Ballantyne C.M., Sharrett A.R., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 1997, 96(December (12)):4219-4225.
19. Davies M.J., Gordon J.L., Gearing A.J., et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993, 171(November (3)):223-229.
20. Ross A.C., Rizk N., O'Riordan M.A., et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis 2009, 49(October (7)):1119-1127.
21. Ross A, Storer N, O'Riordan MA, Dogra V, McComsey G. Longitudinal changes in carotid intima-media thickness and cardiovascular risk factors in human immunodeficiency virus-infected children and young adults compared to healthy controls. Pediatr Infect Dis J;in press.
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(July (7)):412-419.
23. O'Leary D.H., Polak J.F., Wolfson S.K., et al. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991, 22(September (9)):1155-1163.
24. Berenson G.S., Srinivasan S.R., Bao W., Newman W.P., Tracy R.E., Wattigney W.A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998, 338(June (23)):1650-1656.
25. Ishizu T., Ishimitsu T., Yanagi H., et al. Effect of age on carotid arterial intima-media thickness in childhood. Heart Vessels 2004, 19(4):189-195.
26. Manolio T.A., Arnold A.M., Post W., et al. Ethnic differences in the relationship of carotid atherosclerosis to coronary calcification: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008, 197(March (1)):132-138.
27. Phillips A.N., Carr A., Neuhaus J., et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther 2008, 13(2):177-187.
28. Aukrust P., Muller F., Lien E., et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 1999, 179(January (1)):74-82.
29. Triant V.A., Meigs J.B., Grinspoon S.K. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr 2009, 51(July (3)):268-273.
30. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342(March (12)):836-843.
31. Bots M.L., Hoes A.W., Hofman A., Witteman J.C., Grobbee D.E. Cross-sectionally assessed carotid intima-media thickness relates to long-term risk of stroke, coronary heart disease and death as estimated by available risk functions. J Intern Med 1999, 245(3):269-276.
32. Espeland M.A., O'Leary D.H., Terry J.G., Morgan T., Evans G., Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005, 6(March (1)):3.
33. Grunfeld C., Delaney J.A., Wanke C., et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009, (May).
34. Vita J.A., Brennan M.L., Gokce N., et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004, 110(August (9)):1134-1139.
35. El-Bejjani D., Hazen S.L., Mackay W., et al. Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults. HIV Clin Trials 2008, 9(May-June (3)):207-211.